Related Experiment Video

Updated: May 17, 2026

Isolation of Glomeruli and In Vivo Labeling of Glomerular Cell Surface Proteins
09:12

Isolation of Glomeruli and In Vivo Labeling of Glomerular Cell Surface Proteins

Published on: January 18, 2019

Serum adiponectin and fetuin-A levels in children with nephrotic syndrome

Ghada M El-Mashad1, Salwa M Essa

  • 1Department of Pediatrics, Faculty of Medicine, Menoufia, University, Egypt.

The Egyptian Journal of Immunology
|October 23, 2012
PubMed

Insights

In children with nephrotic syndrome, serum adiponectin levels were higher and fetuin-A levels were lower, especially during relapse. These findings suggest adiponectin and fetuin-A may indicate disease activity.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Nephrology

Background:

  • Nephrotic syndrome increases the risk of atherosclerosis and endothelial dysfunction.
  • Adiponectin and fetuin-A are adipokines implicated in metabolic and vascular health.

Purpose of the Study:

  • To evaluate serum adiponectin and fetuin-A levels in children with idiopathic nephrotic syndrome.
  • To determine the relationship between these markers and disease activity.

Main Methods:

  • A study involving 70 children, divided into 35 with idiopathic nephrotic syndrome (relapse or remission) and 35 healthy controls.
  • Serum levels of adiponectin and fetuin-A were measured and compared between groups.

Main Results:

  • Significantly higher adiponectin and lower fetuin-A levels were observed in nephrotic patients compared to controls.
  • Patients in relapse exhibited higher adiponectin and lower fetuin-A than those in remission and controls.
  • A significant negative correlation was found between adiponectin and fetuin-A levels.

Conclusions:

  • Adiponectin and fetuin-A may serve as useful markers for assessing nephrotic syndrome activity.
  • Elevated adiponectin in relapse could be a compensatory response to proteinuria, hypoalbuminemia, and hyperlipidemia.
  • Reduced fetuin-A in relapsed nephrotic syndrome may be linked to proteinuria.
Abstract

More Related Videos

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin07:38

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on: May 6, 2018

Related Concept Videos

Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...